Mark Andrew Smith - 12 Aug 2025 Form 4 Insider Report for CUMMINS INC (CMI)

Signature
/s/ Nicole Y. Lamb-Hale, Attorney-in-Fact
Issuer symbol
CMI
Transactions as of
12 Aug 2025
Net transactions value
-$2,959,625
Form type
4
Filing time
14 Aug 2025, 16:32:14 UTC
Previous filing
04 Mar 2025
Next filing
17 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Smith Mark Andrew VP - Chief Financial Officer 500 JACKSON STREET, COLUMBUS /s/ Nicole Y. Lamb-Hale, Attorney-in-Fact 14 Aug 2025 0001676537

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMI Common Options Exercise $980,580 +6,000 +19% $163.43 37,582 12 Aug 2025 Direct
transaction CMI Common Sale $2,370,000 -6,000 -16% $395.00 31,582 12 Aug 2025 Direct
transaction CMI Common Options Exercise $1,062,295 +6,500 +21% $163.43 38,082 13 Aug 2025 Direct
transaction CMI Common Sale $2,632,500 -6,500 -17% $405.00 31,582 13 Aug 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMI Stock Option (Right-to-Buy) Options Exercise $0 -6,000 -28% $0.000000 15,580 12 Aug 2025 Common 6,000 $163.43 Direct
transaction CMI Stock Option (Right-to-Buy) Options Exercise $0 -6,500 -42% $0.000000 9,080 13 Aug 2025 Common 6,500 $163.43 Direct
holding CMI Stock Option (Right-to-Buy) 21,310 12 Aug 2025 Common 21,310 $142.12 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).